{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:10:07Z","timestamp":1793815807572,"version":"4.6.1"},"reference-count":93,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["JP21H02373"],"award-info":[{"award-number":["JP21H02373"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mesenchymal stem cells (MSCs) are a promising cell source for stem cell therapy of intractable diseases in veterinary medicine, but donor-dependent cellular heterogeneity is an issue that influences therapeutic efficacy. Thus, we previously established immortalized cells that maintain the fundamental properties of primary cells, but functional evaluation had not been performed. Therefore, we evaluated the immunomodulatory capacity of the immortalized canine adipose-derived MSCs (cADSCs) in vitro and in vivo to investigate whether they maintain primary cell functions. C57BL\/6J mice were treated with dextran sulfate sodium (DSS) to induce colitis, injected intraperitoneally with immortalized or primary cADSCs on day 2 of DSS treatment, and observed for 10 days. Administration of immortalized cADSCs improved body weight loss and the disease activity index (DAI) in DSS-induced colitic mice by shifting peritoneal macrophage polarity from the M1 to M2 phenotype, suppressing T helper (Th) 1\/Th17 cell responses and inducing regulatory T (Treg) cells. They also inhibited the proliferation of mouse and canine T cells in vitro. These immunomodulatory effects were comparable with primary cells. These results highlight the feasibility of our immortalized cADSCs as a cell source for stem cell therapy with stable therapeutic efficacy because they maintain the immunomodulatory capacity of primary cells.<\/jats:p>","DOI":"10.3390\/ijms242417484","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T03:16:33Z","timestamp":1702610193000},"page":"17484","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immortalized Canine Adipose-Derived Mesenchymal Stem Cells Maintain the Immunomodulatory Capacity of the Original Primary Cells"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3028-779X","authenticated-orcid":false,"given":"Yuyo","family":"Yasumura","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-6785","authenticated-orcid":false,"given":"Takahiro","family":"Teshima","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"},{"name":"Research Center for Animal Life Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Michishita","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Takano","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Public Health, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Taira","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9451-5854","authenticated-orcid":false,"given":"Ryohei","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1172\/JCI93558","article-title":"The perivascular origin of pathological fibroblasts","volume":"128","author":"Peduto","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Dias, I.E., Pinto, P.O., Barros, L.C., Viegas, C.A., Dias, I.R., and Carvalho, P.P. (2019). Mesenchymal stem cells therapy in companion animals: Useful for immune-mediated diseases?. BMC Vet. Res., 15.","DOI":"10.1186\/s12917-019-2087-2"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Harrell, C.R., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., and Volarevic, V. (2019). Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells, 8.","DOI":"10.3390\/cells8050467"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fvets.2020.00278","article-title":"Stem Cells in Veterinary Medicine-Current State and Treatment Options","volume":"7","author":"Voga","year":"2020","journal-title":"Front. Vet. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/stem.2377","article-title":"Concise Review: Stem Cell Trials Using Companion Animal Disease Models","volume":"34","author":"Hoffman","year":"2016","journal-title":"Stem Cells"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in Clinical Development of Mesenchymal Stromal\/Stem Cells: Concise Review","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Olmedo-Moreno, L., Aguilera, Y., Bali\u00f1a-S\u00e1nchez, C., Mart\u00edn-Montalvo, A., and Capilla-Gonz\u00e1lez, V. (2022). Heterogeneity of In Vitro Expanded Mesenchymal Stromal Cells and Strategies to Improve Their Therapeutic Actions. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051112"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/stem.312","article-title":"In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment","volume":"28","author":"Russell","year":"2010","journal-title":"Stem Cells"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tibtech.2017.10.007","article-title":"Functionally-Relevant Morphological Profiling: A Tool to Assess Cellular Heterogeneity","volume":"36","author":"Marklein","year":"2018","journal-title":"Trends Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","article-title":"MSC-based product characterization for clinical trials: An FDA perspective","volume":"14","author":"Mendicino","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yasumura, Y., Teshima, T., Nagashima, T., Takano, T., Michishita, M., Taira, Y., Suzuki, R., and Matsumoto, H. (2023). Immortalized Canine Adipose-Derived Mesenchymal Stem Cells as a Novel Candidate Cell Source for Mesenchymal Stem Cell Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032250"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/gt.2011.44","article-title":"CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential","volume":"18","author":"Shiomi","year":"2011","journal-title":"Gene Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fgene.2019.00587","article-title":"Human-Derived Corneal Epithelial Cells Expressing Cell Cycle Regulators as a New Resource for in vitro Ocular Toxicity Testing","volume":"10","author":"Fukuda","year":"2019","journal-title":"Front. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semcancer.2019.06.003","article-title":"The multifaceted role of mesenchymal stem cells in cancer","volume":"60","author":"Timaner","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Lamana","year":"2006","journal-title":"Stem Cells"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","article-title":"Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells","volume":"129","author":"Puissant","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","article-title":"Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle","volume":"83","author":"Ramasamy","year":"2007","journal-title":"Transplantation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5966\/sctm.2012-0184","article-title":"Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts","volume":"2","author":"Melief","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/sctm.16-0363","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization","volume":"6","author":"Reverberi","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2249.2010.04256.x","article-title":"Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells","volume":"162","author":"Crop","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies","volume":"10","author":"Noronha","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1038\/s41598-021-82856-3","article-title":"Pluripotency and immunomodulatory signatures of canine induced pluripotent stem cell-derived mesenchymal stromal cells are similar to harvested mesenchymal stromal cells","volume":"11","author":"Shahsavari","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fimmu.2019.01482","article-title":"Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF\/NF-\u03baB-Dependent Mechanism","volume":"10","author":"Sayegh","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Garc\u00eda, L., and Castro-Manrreza, M.E. (2021). TNF-\u03b1 and IFN-\u03b3 Participate in Improving the Immunoregulatory Capacity of Mesenchymal Stem\/Stromal Cells: Importance of Cell-Cell Contact and Extracellular Vesicles. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179531"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: Current state of the art","volume":"13","author":"Fiocchi","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7047201","DOI":"10.1155\/2017\/7047201","article-title":"Th1\/Th2 Balance and Th17\/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced Colitis","volume":"2017","author":"Yang","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-023-01022-z","article-title":"Current perspectives on mesenchymal stromal cell therapy for graft versus host disease","volume":"20","author":"Kadri","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"728190","DOI":"10.3389\/fimmu.2021.728190","article-title":"Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9636897231180128","DOI":"10.1177\/09636897231180128","article-title":"Mesenchymal Stem\/Stromal Cells in Asthma Therapy: Mechanisms and Strategies for Enhancement","volume":"32","author":"Huang","year":"2023","journal-title":"Cell Transpl."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sarsenova, M., Issabekova, A., Abisheva, S., Rutskaya-Moroshan, K., Ogay, V., and Saparov, A. (2021). Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111592"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: Current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lopez-Santalla, M., and Garin, M.I. (2021). Improving the Efficacy of Mesenchymal Stem\/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111507"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhang, H.M., Yuan, S., Meng, H., Hou, X.T., Li, J., Xue, J.C., Li, Y., Wang, Q., Nan, J.X., and Jin, X.J. (2022). Stem Cell-Based Therapies for Inflammatory Bowel Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158494"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0016-5085(90)90290-H","article-title":"A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice","volume":"98","author":"Okayasu","year":"1990","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5217\/ir.2019.09154","article-title":"Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models","volume":"18","author":"Mizoguchi","year":"2020","journal-title":"Intest. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/mmr.2014.3038","article-title":"Modulation of nuclear factor-\u03baB-mediated pro-inflammatory response is associated with exogenous administration of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis","volume":"11","author":"Zuo","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.7150\/thno.47683","article-title":"Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.2535","article-title":"Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity","volume":"218","author":"Yabana","year":"2009","journal-title":"J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.rvsc.2019.06.012","article-title":"Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice","volume":"125","author":"Song","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.joca.2017.01.011","article-title":"Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: In vitro evaluation","volume":"25","author":"Manferdini","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Leelahavanichkul","year":"2009","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13287-019-1447-y","article-title":"MSC-secreted TGF-\u03b2 regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt\/FoxO1 pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12015-013-9455-2","article-title":"Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages","volume":"9","author":"Abumaree","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.yexcr.2017.07.014","article-title":"Bone marrow-derived mesenchymal stem cells propagate immunosuppressive\/anti-inflammatory macrophages in cell-to-cell contact-independent and -dependent manners under hypoxic culture","volume":"358","author":"Takizawa","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_57","first-page":"613","article-title":"Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases","volume":"6","author":"Erben","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/cmi.2014.15","article-title":"Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization","volume":"11","author":"Lin","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/cmi.2012.40","article-title":"Pre-treatment with IL-1\u03b2 enhances the efficacy of MSC transplantation in DSS-induced colitis","volume":"9","author":"Fan","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbrc.2018.03.096","article-title":"Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2","volume":"498","author":"Park","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1038\/s41598-017-04766-7","article-title":"TSG-6 Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells Ameliorates DSS-induced colitis by Inducing M2 Macrophage Polarization in Mice","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6953963","DOI":"10.1155\/2019\/6953963","article-title":"hucMSCs Attenuate IBD through Releasing miR148b-5p to Inhibit the Expression of 15-lox-1 in Macrophages","volume":"2019","author":"Kang","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.rvsc.2018.05.011","article-title":"Canine mesenchymal stem cells treated with TNF-\u03b1 and IFN-\u03b3 enhance anti-inflammatory effects through the COX-2\/PGE2 pathway","volume":"119","author":"Yang","year":"2018","journal-title":"Res. Vet. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/s41598-020-58909-4","article-title":"TNF-\u03b1 and INF-\u03b3 primed canine stem cell-derived extracellular vesicles alleviate experimental murine colitis","volume":"10","author":"An","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1196\/annals.1361.113","article-title":"Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases","volume":"1051","author":"Skurkovich","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/157488810791268681","article-title":"Immunomodulatory effects of adipose-derived stem cells in airway allergic diseases","volume":"5","author":"Cho","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/stem.656","article-title":"Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice","volume":"29","author":"Goodwin","year":"2011","journal-title":"Stem Cells"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Rasmusson","year":"2004","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/stemcells.2008-0283","article-title":"IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model","volume":"27","author":"Cho","year":"2009","journal-title":"Stem Cells"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.0910720107","article-title":"Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma","volume":"107","author":"Nemeth","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","first-page":"G544","article-title":"Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis","volume":"274","author":"Bristol","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ecco-jcc\/jjz200","article-title":"Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1\/Th17 Immune Responses in a PGE2-dependent Manner","volume":"14","author":"Zhou","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.gastro.2015.03.013","article-title":"Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine","volume":"149","author":"Sala","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13287-021-02404-8","article-title":"A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6","volume":"12","author":"Yang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yamamoto, Y., Xiao, Z., and Ochiya, T. (2019). The Immunomodulatory Functions of Mesenchymal Stromal\/Stem Cells Mediated via Paracrine Activity. J. Clin. Med., 8.","DOI":"10.3390\/jcm8071025"},{"key":"ref_83","first-page":"207","article-title":"Immunomodulation by mesenchymal stem cells in veterinary species","volume":"63","author":"Carrade","year":"2013","journal-title":"CompMed"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/scd.2016.0207","article-title":"Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells","volume":"26","author":"Chow","year":"2017","journal-title":"Stem Cells Dev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/scd.2007.0153","article-title":"Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells","volume":"17","author":"Kang","year":"2008","journal-title":"Stem Cells Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1007\/s11033-022-07648-y","article-title":"Interferon-\u03b3 enhances the immunosuppressive ability of canine bone marrow-derived mesenchymal stem cells by activating the TLR3-dependent IDO\/kynurenine pathway","volume":"49","author":"Deng","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/rme.15.69","article-title":"Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: A canine model of human fistulizing Crohn\u2019s disease","volume":"11","author":"Ferrer","year":"2016","journal-title":"Regen. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1098029","DOI":"10.3389\/fvets.2023.1098029","article-title":"Local, systemic and immunologic safety comparison between xenogeneic equine umbilical cord mesenchymal stem cells, allogeneic canine adipose mesenchymal stem cells and placebo: A randomized controlled trial","volume":"10","author":"Rico","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3748\/wjg.v21.i16.4779","article-title":"Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease","volume":"21","author":"Chinnadurai","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Yu, Y., Song, E.M., Lee, K.E., Joo, Y.H., Kim, S.E., Moon, C.M., Kim, H.Y., Jung, S.A., and Jo, I. (2017). Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183141"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"30696","DOI":"10.1038\/srep30696","article-title":"Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"18228","DOI":"10.3748\/wjg.v20.i48.18228","article-title":"Intravenous vs intraperitoneal mesenchymal stem cells administration: What is the best route for treating experimental colitis?","volume":"20","author":"Schneider","year":"2014","journal-title":"World J. Gastroenterol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/24\/17484\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:38:56Z","timestamp":1760132336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/24\/17484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":93,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["ijms242417484"],"URL":"https:\/\/doi.org\/10.3390\/ijms242417484","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}